NASDAQ · BIB
ProShares Ultra Nasdaq Biotechnology
$120.53+$0.00 (0.0%)
ProShares Ultra Nasdaq Biotechnology’s quoted price sits in the upper half of its reported 52-week range, 4.64% below the high.
Loading market information…
AMEX · URSP · USD
Stock price, dividends
Quote as of Oct 30, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
ProShares - Ultra S&P 500 Equal Weight’s quoted price sits in the upper half of its reported 52-week range, 5.43% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
ProShares - Ultra S&P 500 Equal Weight’s forward annual dividend is $0.76 per share, paid quarterly. The forward yield is 1.5% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
THE COMPANY BEHIND THE TICKER
The ProShares Ultra S&P 500 Equal Weight fund strives to provide daily financial outcomes that are double the percentage change of the S&P 500 Equal Weight Index, before any management fees or operating expenses are subtracted.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 31, 2026, 10:04 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
KEEP COMPARING
$120.53+$0.00 (0.0%)
ProShares Ultra Nasdaq Biotechnology’s quoted price sits in the upper half of its reported 52-week range, 4.64% below the high.
$49.29+$0.01 (+0.02%)
Neuberger Berman Flexible Credit Income ETF’s quoted price sits in the lower half of its reported 52-week range, 4.88% below the high.
$34.92+$2.43 (+7.48%)
WBI Power Factor High Dividend ETF’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$62.63-$1.05 (-1.65%)
Fidelity Advisor Managed Retirement 2025 Fund Class A’s quoted price sits in the upper half of its reported 52-week range, 2.9% below the high.
$35.24$0.00 (+0.07%)
LeaderShares Equity Skew ETF’s quoted price sits in the upper half of its reported 52-week range, 9.5% below the high.
$29.12-$0.43 (-1.46%)
MRP SynthEquity ETF’s quoted price sits in the lower half of its reported 52-week range, 16.68% below the high.
$8.79-$0.03 (-0.34%)
Regents Park Hedged Market Strategy ETF’s quoted price sits in the lower half of its reported 52-week range, 23.5% below the high.
$17.67+$0.41 (+2.35%)
ProShares UltraShort Dow30’s quoted price sits in the lower half of its reported 52-week range, 24.13% below the high.
